Navigation Links
AmLactin(R) Family of Moisturizers Has a New Look


MINNEAPOLIS, May 11 /PRNewswire/ -- Upsher-Smith has revamped its AmLactin(R) family of moisturizers packaging to feature more appealing labels. Just in time for summer, dry skin sufferers can now find relief in style. With vibrant colors and easy to use packaging, any of the AmLactin(R) products are perfect to grab and go. The sleek and smooth design of the new bottles and tubes is dually colored in white and light shades of green, purple and blue, to differentiate the products.


The AmLactin(R) family of moisturizers features the MultiPlex Moisturizing System(TM), a unique combination of emollient and humectant factors, plus alpha-hydroxy acids formulated to keep the skin soft and hydrated. The line includes AmLactin(R), which is available in a lotion or cream, AmLactin XL(R), a stronger formula and AmLactin(R) Foot Cream Therapy.

"We wanted our customers to find our products more easily while preserving the look of a serious moisturizer," said Mark Evenstad, President of Upsher-Smith Laboratories, Inc.

AmLactin(R) and AmLactin XL(R) are very effective treatments to help manage dry skin associated with keratosis pilaris, eczema, psoriasis and atopic dermatitis. AmLactin XL(R) contains the patented ULTRAPLEX(TM) formulation, a high-potency blend of three alpha-hydroxy moisturizing compounds. AmLactin XL(R) is clinically proven to provide superior hydration and is recommended by dermatologists for severe dry skin.

The AmLactin(R) family of moisturizers are the number one dermatologist- and podiatrist-recommended brand of moisturizers and are readily available without a prescription at fine retailers nationwide and online. Ask your pharmacist or visit: Target, CVS, Walgreens, Rite Aid, Costco or Wal-Mart. Order online at,, or

For more information, call 1-800-654-2299 or visit For a more light-hearted yet informative source for information about keratosis pilaris, visit our site,

Upsher-Smith Laboratories, Inc. is a rapidly-growing pharmaceutical company that manufactures and markets both prescription and consumer products. Privately held since 1919, the company strives to recognize the unmet healthcare needs of its customers. Upsher-Smith prides itself on providing safe, effective and economical therapies to the ever-challenged healthcare environment. For additional information, visit

SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New AmLactin(R) Foot Cream Immerses Feet in Moisture
2. Almost Family to Present at Two Upcoming Conferences
3. Dr. Dan Tobin, Family Caregiving Expert, Featured on
4. Almost Family Reports First Quarter 2009 Results
5. ABCs Extreme Makeover: Home Edition Helps Family Coping with Primary Immunodeficiency Disease
6. Almost Family, Inc. to Report First Quarter 2009 Financial Results
7. Survey finds nearly half of Americans concerned they or their family may get sick from swine flu
8. Family History is Key Risk Factor in Developing Osteoporosis
9. Video: IAVA and Ad Council Build on Success of Groundbreaking Veterans Campaign with New Friends and Family Element
10. Rotator Cuff Tears: Are They All in the Family?
11. Photos: How You Can Help Protect Yourself & Your Family From Swine Flu (H1N1)
Post Your Comments:
(Date:12/1/2015)... ... , ... Integrated Rental Services (“Integrated Rental”), a growing medical ... , With support from JII, Integrated Rental is poised for expansion while improving ... research labs and medical facilities across the United States. , General Manager Robert ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... Califia ... today announced that its iconic bottle has won top honors in Beverage World Magazine’s ... The Company also announced that it has been selected as a 2015 U.S.A. Taste ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... we have seen vast improvements in scientific research and discoveries, leading us to ... increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s cross-platform edition of ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance of ... is the focus of numerous abstracts accepted for presentation here, at the 101st ... Nine abstracts highlight the use of Volpara Solutions’ quantitative breast imaging software tools ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next ... selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an ... was recognized as a finalist in the category of Digital Solutions for its ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 2015 Breg, Inc ., a premier ... that it has been awarded three contracts by Novation, ... Novation will have access to improved pricing for Breg,s ... soft goods dedicated to advancing orthopedic care.  ... U.S. population, rising prevalence of chronic conditions and the ...
(Date:12/1/2015)... , December 1, 2015 Russia ... III clinical trials. 70% of new drugs registered in Europe ... in Russia . --> Russia has always ... 70% of new drugs registered in Europe in ... --> Russia has always been a ...
(Date:12/1/2015)... 1, 2015 CytRx Corporation (NASDAQ: CYTR ... oncology, today announced that it has reached its enrollment ... Phase 3 clinical trial of aldoxorubicin in patients with ... to be completed in Q1 2016. The Phase 3 trial ... Special Protocol Assessment from the FDA at 79 sites ...
Breaking Medicine Technology: